Multimodal Prediction of Dementia with up to 10 Years Follow Up: The Gothenburg MCI Study

作者: Carl Eckerström , Erik Olsson , Niklas Klasson , Josef Berge , Arto Nordlund

DOI: 10.3233/JAD-141053

关键词:

摘要: Background: Neuropsychological tests, CSF A42, T-tau, P-tau181, hippocampal volume, and white matter lesions have been shown to predict conversion dementia in patients with mild cognitive impairment (MCI). Objective: To examine the predictive value of combinations these markers if absence pathological provides a lasting reduction rates. Methods: The Gothenburg MCI study is clinically based study. Seventy-three were included present sub-study followed for maximum ten years. Thirty-four converted (18 AD) 39 remained stable. At inclusion, classified into positive or negative risk groups according results from neuropsychological testing (Rey auditory verbal learning test, Boston naming Trail making test B), biomarkers (amyloid 42, P-tau181) MRI scans (hippocampal lesions). Results: B (TMT-B) was best single predictor prediction (AUC 0.89, HR 25), T-tau AD 0.97, 41). combination volume TMT-B (HR 37). Conclusion: markers, predicted general dementia. provided long-time protection

参考文章(41)
B Reisberg, T Crook, M J de Leon, S H Ferris, Global Deterioration Scale (GDS). Psychopharmacology Bulletin. ,vol. 24, pp. 661- 663 ,(1988)
Osa Segal, Harold Goodglass, Edith Kaplan, Sandra Weintraub, Boston Naming Test ,(2001)
Ineke A. van Rossum, Pieter Jelle Visser, Dirk L. Knol, Wiesje M. van der Flier, Charlotte E. Teunissen, Frederik Barkhof, Marinus A. Blankenstein, Philip Scheltens, Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease. Journal of Alzheimer's Disease. ,vol. 29, pp. 319- 327 ,(2012) , 10.3233/JAD-2011-111694
Timo Erkinjuntti, D. Inzitari, L. Pantoni, A. Wallin, P. Scheltens, K. Rockwood, G. C. Roman, H. Chui, D. W. Desmond, Research criteria for subcortical vascular dementia in clinical trials. Journal of Neural Transmission-supplement. ,vol. 59, pp. 23- 30 ,(2000) , 10.1007/978-3-7091-6781-6_4
Carl Eckerström, Erik Olsson, Maria Bjerke, Helge Malmgren, Åke Edman, Anders Wallin, Arto Nordlund, A combination of neuropsychological, neuroimaging, and cerebrospinal fluid markers predicts conversion from mild cognitive impairment to dementia. Journal of Alzheimer's Disease. ,vol. 36, pp. 421- 431 ,(2013) , 10.3233/JAD-122440
Ana Espinosa, Montserrat Alegret, Sergi Valero, Georgina Vinyes-Junqué, Isabel Hernández, Ana Mauleón, Maitée Rosende-Roca, Agustín Ruiz, Oscar López, Lluís Tárraga, Mercè Boada, A Longitudinal Follow-Up of 550 Mild Cognitive Impairment Patients: Evidence for Large Conversion to Dementia Rates and Detection of Major Risk Factors Involved Journal of Alzheimer's Disease. ,vol. 34, pp. 769- 780 ,(2013) , 10.3233/JAD-122002
Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh, “Mini-mental state” Journal of Psychiatric Research. ,vol. 12, pp. 189- 198 ,(1975) , 10.1016/0022-3956(75)90026-6
Arto Nordlund, Sindre Rolstad, Per Hellström, Magnus Sjögren, Stefan Hansen, Anders Wallin, The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition Journal of Neurology, Neurosurgery & Psychiatry. ,vol. 76, pp. 1485- 1490 ,(2005) , 10.1136/JNNP.2004.050385
Anders Wallin, Åke Edman, Kaj Blennow, Carl-Gerhard Gottfries, Ingvar Karlsson, Björn Regland, Magnus Sjögren, Stepwise Comparative Status Analysis (STEP): A Tool for Identification of Regional Brain Syndromes in Dementia: Journal of Geriatric Psychiatry and Neurology. ,vol. 9, pp. 185- 199 ,(1996) , 10.1177/089198879600900406
Michael Ewers, Cathal Walsh, John Q. Trojanowski, Leslie M. Shaw, Ronald C. Petersen, Clifford R. Jack, Howard H. Feldman, Arun L.W. Bokde, Gene E. Alexander, Philip Scheltens, Bruno Vellas, Bruno Dubois, Michael Weiner, Harald Hampel, Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance Neurobiology of Aging. ,vol. 33, pp. 1203- 1214 ,(2012) , 10.1016/J.NEUROBIOLAGING.2010.10.019